Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Norbert Marschner

20PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpidemiological methodsHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

Sort by Publication Date:
|Mar 18, 2026
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registry.

Patrick Marschner, Kai Ringwald, Marc Thill

|Dec 30, 2025
First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex.

Viktor Grünwald, Karen Rußwurm, Ralf Eckert

|Sep 09, 2025
Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.

Karin Potthoff, Jens Uhlig, Lutz Jacobasch

|Jul 03, 2024
Head-to-head comparison of treatment sequences in advanced pancreatic cancer-Real-world data from the prospective German TPK clinical cohort study.

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker

|Jan 19, 2024
Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients.

Nina Haug, Martina Jänicke, Benjamin Kasenda

|Sep 02, 2022
FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.

Norbert Marschner, Susanna Hegewisch-Becker, Marcel Reiser

Pageof 4

Frequent Collaborators

2 joint publications

Michael Staehler

2 joint publications

Nina Haug

1 joint publications

Benjamin Kasenda

1 joint publications

Melanie Frank

1 joint publications

Gerald Prager

1 joint publications

Viktor Grünwald

1 joint publications

Martin Bögemann

1 joint publications

Patrick Marschner

1 joint publications

Kai Ringwald

1 joint publications

Anja Welt

Frequent Collaborators

2 joint publications

Michael Staehler

2 joint publications

Nina Haug

1 joint publications

Benjamin Kasenda

1 joint publications

Melanie Frank

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.1K
<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.1K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

6.0K
See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.1K
<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.1K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

6.0K
See more related videos